Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Fourth quarter revenue of $168 million and full year revenue of $634 millionFourth quarter orders and revenues sequentially increased 11% and 8% respectivelyOrders outpaced revenue by 6% in the fourth...
-
Record production and strong margin expansion drive record free cash flow of $272 million while funding high-return growth All amounts are in United States dollars, unless otherwise stated. TORONTO,...
-
Toronto, Feb. 18, 2025 (GLOBE NEWSWIRE) -- It takes one voice to make a difference. RTOERO has launched its Vibrant Voices campaign to mobilize voters and ensure seniors’ issues are front and...
-
Note to editors: A media kit, including the broadcast of the full press event, patient biographies, b-roll footage, and still images, is available here (video footage to be enclosed at Noon). ...
-
NEWARK, Del:, Feb. 16, 2025 (GLOBE NEWSWIRE) -- The global operating room equipment market is poised for significant growth, with projections estimating a market value of USD 38,610.9 million in...
-
Fourth Quarter 2024 Highlights Sales increased 2% to $10.6 billion, in-line with global light vehicle productionDiluted earnings per share of $0.71 and Adjusted diluted earnings per share of...
-
Wilmington, Delaware, United States, Transparency Market Research Inc. – , Feb. 12, 2025 (GLOBE NEWSWIRE) -- According to a recent market analysis, the dental composites market is projected to grow...
-
OTTAWA, Ontario, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Today marks Canada’s Agriculture Day, a celebration of the vital contributions made by everyone involved at every stage of the value chain who...
-
Dr. Cañizares, a globally recognized expert in power system stability and renewable energy integration, highlighted the significant potential of hydrogen in remote communities and areas with high...
-
BURNABY, British Columbia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation...